No­vo Hold­ings is look­ing for a few good su­per­bug biotechs in need of ear­ly-stage fund­ing — in­vest­ing $165M

There aren’t many ven­ture funds out there in biotech land that em­brace star­tups look­ing to de­vel­op a new gen­er­a­tion of an­tibi­otics for the grow­ing men­ace …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.